4-(1-(3-Methoxy-4-(4-phenethylthiazol-2-yl)phenyl)-1H-1,2,3-triazol-4-yl)butan-1-ammonium 2,2,2-trifluoroacetate

ID: ALA4848230

PubChem CID: 138691127

Max Phase: Preclinical

Molecular Formula: C26H28F3N5O3S

Molecular Weight: 433.58

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(-n2cc(CCCCN)nn2)ccc1-c1nc(CCc2ccccc2)cs1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C24H27N5OS.C2HF3O2/c1-30-23-15-21(29-16-19(27-28-29)9-5-6-14-25)12-13-22(23)24-26-20(17-31-24)11-10-18-7-3-2-4-8-18;3-2(4,5)1(6)7/h2-4,7-8,12-13,15-17H,5-6,9-11,14,25H2,1H3;(H,6,7)

Standard InChI Key:  FJPVKQMTPDNAIH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 40  0  0  0  0  0  0  0  0999 V2000
   17.0367  -16.1743    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.6303  -15.4653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2195  -16.1716    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.3413  -15.0548    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.9194  -15.0548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2084  -15.4653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.9194  -14.2339    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0844  -17.9853    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7557  -18.4637    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4222  -17.9785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1590  -17.1926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3349  -17.2006    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7599  -19.2862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0453  -19.7038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0490  -20.5281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7668  -20.9358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4822  -20.5173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4749  -19.6943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7750  -21.7626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1098  -22.2535    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.3685  -23.0368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1936  -23.0316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4463  -22.2451    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6405  -16.5206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4618  -16.6001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9434  -15.9280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7645  -16.0076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2419  -15.3355    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2008  -20.9217    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.9123  -20.5051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6846  -23.6967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3555  -24.4489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8423  -25.1140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5098  -25.8693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9959  -26.5340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6571  -25.0205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1493  -25.6821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8139  -26.4412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  5  7  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  2  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  9 13  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 19  2  0
 16 19  1  0
 11 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 17 29  1  0
 29 30  1  0
 22 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 38  2  0
 37 36  2  0
 36 33  1  0
 37 38  1  0
M  END

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

TRYR Trypanothione reductase (236 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania infantum (5912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 433.58Molecular Weight (Monoisotopic): 433.1936AlogP: 4.47#Rotatable Bonds: 10
Polar Surface Area: 78.85Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.21CX LogP: 4.79CX LogD: 2.19
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.37Np Likeness Score: -1.35

References

1. Revuelto A, de Lucio H, García-Soriano JC, Sánchez-Murcia PA, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S..  (2021)  Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles.,  64  (9.0): [PMID:33945281] [10.1021/acs.jmedchem.1c00206]

Source